(Eligibility and Benefits) Wegovy is used to treat obesity in adults with a body mass index (BMI) of 30 or higher (obese) or 27 or higher (overweight) who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol
In addition, BPA can directly alter neuronal physiology by changing voltage-gated 26 and/or ligand-gated 27,28,29 ion channel activity
Anecdotal reports likely stem from significant weight loss revealing more of the penile shaft previously obscured by abdominal fat, creating an optical illusion of increased size rather than actual anatomical growth
Bokobza E, Hinault C, Tiroille V, Clavel S, Bost F, Chevalier N
Com a disponibilidade de opes mais seletivas, o GHRP-6 considerado clinicamente obsoleto para a maioria das indicaes
This mechanism is why SGLT-2 inhibitors carry FDA warnings about increased UTI and genital infection risk